Skip to main content
BioMed Research International logoLink to BioMed Research International
. 2017 Jun 20;2017:9382083. doi: 10.1155/2017/9382083

Postnatal Growth in a Cohort of Sardinian Intrauterine Growth-Restricted Infants

Maria Grazia Clemente 1,*, Giampiero Capobianco 2, Paolo Mattia Galasso 1, Francesco Dessole 2, Giuseppe Virdis 2, Maria Grazia Sanna 3, Mauro Giorgio Olzai 3, Lino Argiolas 4, Salvatore Dessole 2, Roberto Antonucci 1
PMCID: PMC5496105  PMID: 28713832

Abstract

Recent studies have shown that infants with intrauterine growth restriction (IUGR) undergo catch-up growth during infancy. The aim of our study was to evaluate the postnatal growth in a cohort of IUGR infants born in a tertiary-level Obstetric University Hospital of Northern Sardinia. An observational retrospective study was conducted on 12 IUGR (group A) and 12 control infants (group B) by measuring the anthropometric parameters of weight (W), length (L) and head circumference (HC) from birth to the 3rd postnatal year. At birth, significant differences were found between group A and group B with regard to all the auxological parameters (W, mean 1846.6 versus 3170.8 g, p < 0.0001; HC, 30.1 versus 34.4 cm, p < 0.0001; L, mean 43.4 versus 49.4 cm, p < 0.0001). During the 1st year, 8 of 12 (70%) IUGR infants exhibited a significant catch-up growth in the 3 anthropometric parameters and a regular growth until the 3rd year of follow-up. The majority but not all infants born with IUGR in our series showed significant postnatal catch-up growth essentially during the first 12 months of life. An improved knowledge of the causes of IUGR will help to develop measures for its prevention and individualized treatment.

1. Introduction

A combination of environmental, genetic, and epigenetic factors, still partially unknown, can be responsible for a condition in which a fetus is unable to reach its genetically determined growth potential: this condition is defined as intrauterine growth restriction (IUGR) [1, 2]. The IUGR fetus begins to lose its growth potential during the first trimester of pregnancy, mainly as a result of uterine hypoperfusion often associated with thin umbilical cord [1, 2]. The causes can be maternal, fetal, or placental. Preeclampsia, pathologic conditions of the umbilical arteries, maternal smoking, and unbalanced diet are known risk factors of IUGR [36]. It is essential to diagnose IUGR by ultrasound scan before the 28th week of gestation and to monitor its evolution throughout pregnancy. In this regard, Doppler flow measurement of the fetal vessels (namely, umbilical artery, ductus venosus, and middle cerebral artery) has been found to be particularly helpful [7]. The circulatory status of the fetus is assessed especially in the middle cerebral artery, to determine the appropriate timing of delivery, that needs to be neither too early nor too late for a better outcome and prognosis [7, 8].

Clinical studies have shown that IUGR is a condition associated not only with an increased perinatal mortality, but also with significant morbidity later in life, including short stature, metabolic syndrome, and neurocognitive impairment [911]. The “symmetric” form of IUGR, defined by significant reduction of all anthropometric parameters including a small head circumference for gestational age, is associated with a worst prognosis compared to the “asymmetric” form of IUGR, in which the head circumference is within the normal range, and a favorable, complication-free postnatal course is generally observed [12, 13]. Among term infants, morbidity and mortality are 5-30-fold higher in low birth weight infants (LBWI) compared to infants with birth weight within the normal range (10th–90th centile) [12, 13].

The postnatal catch-up growth begins as soon as infants move to a more favorable environment and becomes evident during the first months of life. However, not all IUGR infants exhibit a postnatal catch-up growth, likely depending on the underlying causative factor/s and genetic diversity [14].

The present study reports results from a 3-year follow-up of a cohort of Sardinian IUGR infants with special emphasis on the postnatal catch-up growth.

2. Study Population and Methods

2.1. Study Population

In the year 2013, a total 27 IUGR diagnoses were made among infants born in the Gynecologic and Obstetric Clinic of the University of Sassari, Italy. Gestational age (GA) was defined on the basis of ultrasonographic estimation (Voluson E8 ultrasound system, GE Healthcare, Fairfield CT, USA) performed at the time of the first scan, as recommended (SIEOG Italian guidelines), and at about 20, 28, and 36 weeks' gestation [15]. Distributions of all measurements were similar to previously reported reference cohorts (data not reported). At the 20-week scan, details about medical history and demographic characteristics of the pregnant women were collected retrospectively. At this time, women were also informed about fetal anatomy and biometric measurements, as well as uterine and umbilical artery Doppler flow velocimetry data [15]. Ultrasonographic measurements of fetal biparietal diameter, head circumference, abdominal circumference, and femur length were performed according to standard techniques. The Hadlock equations and reference standard were used to calculate the fetal weight (EFW) centile, and EFW values less than the 10th centile defined the IUGR [15]. At the 36 week scan, pregnant women were informed about previously undiagnosed placenta praevia, severe oligohydramnios, a previously undiagnosed fetal abnormality, or noncephalic presentation [15]. Women were selected for additional, clinically indicated scans in the third trimester of pregnancy as per routine clinical care, using local and national guidelines (e.g., SIEOG guidelines). The indications for cesarean section (CS) included a not reassuring cardiotocography (85%) and a reversed end diastolic flow of umbilical artery at ultrasound evaluation (15%).

As 13 families moved out of the Sassari province and 2 newborns unfortunately deceased, the access to postnatal data was available for 12 IUGR infants (F : M = 8 : 4), enrolled as group A. Twelve term infants with a birth weight greater than 2,500 g (F : M = 8 : 4) were enrolled as a control group (group B). The parents of all the infants enrolled in this study provided informed consent.

Group A and group B newborns' main parameters are shown in Table 1, ordered by GA (column 4). Among group A, 3 of 12 infants (25%; Table 1, A1–A4) were born preterm and with a very low birth weight (VLBW), ranging from 1115 to 1400 g. The remaining group A, namely, 5 (41,6%) late preterm (Table 1, A5–A8) and 4 (33,3%) at term infants (Table 1, A9–A12), were all but one born with low birth weight (LBW), ranging from 1510 to 2450 g, and one with VLBW (1405 g).

Table 1.

Main parameters of the enrolled newborns, both group A and B.

Group A infants Sex Delivery G.A. APGAR
at 5′
W
(g)
W
(centile)
L
(cm)
L
(centile)
CC
(cm)
CC
(centile)
A1 F CS 32 7 1115 3rd 37,0 3rd 27,0 3–10th
A2 F CS 32 + 4 8 1300 10th 36,0 <3rd 28,0 10th
A3 M CS 33 8-9 1400 3rd 38,0 <3rd 28,0 3rd
A4 F CS 34 9 1405 <3rd 44,0 50th 27,5 <3rd
A5 M CS 35 9 1583 <3rd 45,0 25th 31,5 25th
A6 F CS 36 9 1950 3rd 42,5 3rd 31,0 3rd
A7 F CS 36 + 3 9 2400 25th 44,5 10th 32,5 25th
A8 M CS 36 + 6 9 1930 <3rd 43,0 <3rd 31,0 10th
A9 M CS 37 9 2040 <3rd 43,5 <3rd 32,0 10th
A10 F CS 37 9 1510 <3rd 42,0 <3rd 28,0 <3rd
A11 F CS 37 + 2 9 2450 10–25th 45,3 10th 32,0 10–25th
A12 F CS 37 + 2 9 2300 3–10th 46,0 10–25th 32,5 10th

Group B infants Sex Delivery G.A. APGAR
at 5′
W
(g)
W
(centile)
L
(cm)
L
(centile)
CC
(cm)
CC
(centile)

B1 F VD 38 9 2900 50th 49,0 50th 33,5 50th
B2 F VD 38 9 3000 50th 50,0 50–75th 33,5 50th
B3 M VD 38 + 2 9 2900 10–25th 49,5 50th 33,0 25th
B4 M VD 39 9 3400 75th 47,0 10th 36,0 90th
B5 F CS 39 + 2 9 2900 10–25th 48,5 25–50th 33,0 25th
B6 M CS 40 + 2 9 3600 50th 49,0 10–25th 35,0 50th
B7 F VD 40 + 4 9 2900 25–50th 48,5 25th 34,0 50th
B8 F VD 41 9 2800 10th 49,5 25–50th 34,0 50th
B9 F VD 41 9 2800 10th 48,3 10th 35,0 75th
B10 F VD 41 9 3350 50th 50,5 50–75th 35,0 75th
B11 M VD 41 + 1 9 3500 25–50th 51,5 50th 35,0 50th
B12 F VD 42 9 4000 >90th 51,0 50–75th 35,5 75th

All group A but only 2 group B infants had CS births (Table 1, B5-B6).

2.2. Methods

This is an observational study conducted by retrospective collection of the measures of weight (W), length (L), and head circumference (HC), at birth and at 3-month intervals during the first year, then annually in the second and third years of follow-up (W and L). All values were plotted and recorded in the growth charts as follows: (1) weight to age, (2) length to age, and (3) head circumference to age (Center for Disease Controls, Atlanta, GA, USA).

2.3. Statistical Analysis

Student's t-test was used to compare groups, considering significant a value of p < 0.05.

3. Results

At birth, significant differences were found between group A and group B infants with regard to all anthropometric parameters considered in this study (W, mean 1846.6 versus 3170.8 g, p < 0.0001; HC, 30.1 versus 34.4 cm, p < 0.0001; L, mean 43.4 versus 49.4 cm, p < 0.0001).

During the first year of life, a significant catch-up growth led to cover the differences in L (mean 72.6 versus 76.5 cm, p = ns) and to reduce those in W (mean 7861.0 versus 9165.0 g, p = 0.02) and HC (mean 43.5 versus 45.7 cm, p = 0.04) between the two study groups. At the age of 1 year, 8 (70%) group A infants were comparable to group B infants with respect to the 3 anthropometric parameters (Figure 1). However, analysis of data from individual patients revealed that 4 of 12 (30%) IUGR infants (Table 1, A2, A6, A8, and A10) did not exhibit catch-up growth during the first postnatal year with minimal improvement during the second and third years of follow-up (Figure 1). Categories of centiles for weight, length, and head circumference of IUGR infants at 12 months of life are reported in Tables 2, 3, and 4.

Figure 1.

Figure 1

Percentage of group A infants below and above the 3rd centile cut-off for length (left panel) and weight (right panel) at birth, at 12 months (12 m) and 36 months (36 m) of age.

Table 2.

Weight centile categories of IUGR (group A) infants at 12 months of postnatal life.

Male Female Total
<3rd centile 1 3 4
3rd–50th centile 2 3 5
>50th centile 1 2 3
Total 4 8 12

Table 3.

Length centile categories of IUGR (group A) infants at 12 months of postnatal life.

Male Female Total
<3rd centile 1 3 4
3rd–50th centile 2 4 6
>50th centile 1 1 2
Total 4 8 12

Table 4.

Head Circumference centile categories of IUGR (group A) infants at 12 months of postnatal life.

Male Female Total
<3rd centile 0 3 3
3rd–50th centile 3 3 6
>50th centile 1 2 3
Total 4 8 12

It deserves a note that among those who did not show postnatal catch-up growth, the only IUGR infant born at term (A10, Table 1) was discovered to be affected by the rare Pallister-Killian syndrome, caused by tetrasomy of chromosome 12p which is characterized by facial dysmorphism, rhizomelic limb shortness, and small hands and feet, along with corpus callosum hypoplasia. Moreover, during the postnatal years of follow-up, one of the IUGR preterm infants (A2; GA = 32 + 4; Table 1) showed failure to thrive, and it is currently under pediatric endocrinology evaluation.

4. Discussion

The majority of IUGR infants in our series showed significant postnatal catch-up growth during the first 12 months of life, and regular growth until 3 years of age.

Several studies in literature have reported on the postnatal catch-up growth in preterm IUGR and SGA infants, but only a few studies exist on term IUGR infants [1, 1012].

One study conducted in North America (USA) on 42 IUGR infants has calculated growth velocity, which was significantly higher in IUGR infants compared to the control group (3.58 kg/m2 versus 2.36 kg/m2) during the first 12 months of life [13].

Another study, conducted in North Europe on 73 IUGR newborns, found catch-up growth in up to 90% of cases during the first year of life; 7% of infants among those who did not have significant catch-up growth exhibited neurological and cognitive impairment [3].

This study was not a clinical trial and was also limited by both its retrospective, observational design and the small sample size. Even with these limitations of the study, our results further confirm those reported by others. All the term IUGR infants but the one affected by Pallister-Killian syndrome exhibit a catch-up growth. More than half of the preterms IUGR did show also a significant catch-up growth, and it was significantly greater during the first 12 months of life [9].

It was not possible for us to determine for each single case whether maternal or fetal factors played a role in the development of IUGR, as well as the role played by genetic, epigenetic, and environmental factors, or likely the complex combination of multiple factors on the catch-up growth and outcome during the postnatal life.

Interesting, the recent personalized medicine approach through the Newborn Individualized Developmental Care and Assessment Program (NIDCAP) has been the focus of a study conducted on preterm infants born with severe IUGR by a multidisciplinary research working group of Harvard University [16, 17]. The NIDCAP was shown to be effective in ameliorating the neurobehavior, electrophysiology and brain structure outcomes compared to IUGR controls [16, 17]. At least 2/3 of our IUGR infants required special assistance at the Newborn Intensive Care Unit (NICU). We can therefore speculate that also our infants compromised by severe IUGR who showed postnatal catch-up growth might have had significant benefit from an individualized developmental care approach during NICU stay.

Moreover, methods of infant feeding (breast-feeding versus formula feeding) and other nutritional factors (including iron, zinc, and vitamins) might play a critical role in the catch-up growth during the first months of life [18, 19] and would deserve further, more extensive, investigation.

Acknowledgments

The study was partially funded by the School of Biomedical Sciences, Addressing Gender Medicine (Man, Woman, and Child), Sassari University, Italy, and partially by the Autonomous Region of Sardinia, Italy. The authors are grateful to the pediatric endocrinologist Dr. Carlo Burrai for providing clinical postnatal information of one of the IUGR infants.

Abbreviations

CS:

Cesarean section

EFW:

Estimated fetal weight

GA:

Gestational age

HC:

Head circumference

IUGR:

Intrauterine growth restriction

L:

Length

LBWI:

Low birth weight infants

NIDCAP:

Newborn Individualized Developmental Care and Assessment Program

NICU:

Newborn Intensive Care Unit

PROM:

Premature rupture of the membrane

SGA:

Small for gestational age

VD:

Vaginal delivery

VLBW:

Very low birth weight

W:

Weight.

Conflicts of Interest

The authors declare that there are no conflicts of interest regarding the publication of this paper.

Authors' Contributions

The first three authors (Maria Grazia Clemente, Giampiero Capobianco, and Paolo Mattia Galasso) contributed equally and wrote the first draft of the paper. Francesco Dessole, Giuseppe Virdis, and Giampiero Capobianco selected IUGR infants for the study, did the prenatal ultrasound evaluation, and analyzed the gestational auxological data, Maria Grazia Sanna and Mauro Giorgio Olzai did the perinatal physical evaluation of the study population, and Maria Grazia Clemente, Paolo Mattia Galasso, and Lino Argiolas collected and analyzed the perinatal and postnatal clinical records and anthropometric data. Salvatore Dessole and Roberto Antonucci were co-senior authors. All participated in writing the paper. The final version was approved by everyone.

References

  • 1.Puccio G., Giuffré M., Piccione M., Piro E., Rinaudo G., Corsello G. Intrauterine growth restriction and congenital malformations: A retrospective epidemiological study. Italian Journal of Pediatrics. 2013;39(1, article no. 23) doi: 10.1186/1824-7288-39-23. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Tabano S., Colapietro P., Cetin I., et al. Epigenetic modulation of the IGF2/H19 imprinted domain in human embryonic and extra-embryonic compartments and its possible role in fetal growth restriction. Epigenetics. 2010;5(4):313–324. doi: 10.4161/epi.5.4.11637. [DOI] [PubMed] [Google Scholar]
  • 3.Sehested L. T., Pedersen P. Prognosis and risk factors for intrauterine growth retardation. Danish Medical Journal. 2014;61(4):p. A4826. [PubMed] [Google Scholar]
  • 4.Banderali G., Martelli A., Landi M., et al. Short and long term health effects of parental tobacco smoking during pregnancy and lactation: a descriptive review. Journal of Translational Medicine. 2015;13, article 327:10–1186. doi: 10.1186/s12967-015-0690-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Mayor R. S., Finch K. E., Zehr J., et al. Maternal high-fat diet is associated with impaired fetal lung development. American Journal of Physiology - Lung Cellular and Molecular Physiology. 2015;309(4):L360–L368. doi: 10.1152/ajplung.00105.2015. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Fadda G. M., Capobianco G., Balata A., et al. Routine second trimester ultrasound screening for prenatal detection of fetal malformations in Sassari University Hospital, Italy: 23 years of experience in 42,256 pregnancies. European Journal of Obstetrics Gynecology and Reproductive Biology. 2009;144(2):110–114. doi: 10.1016/j.ejogrb.2009.02.045. [DOI] [PubMed] [Google Scholar]
  • 7.Aditya I., Tat V., Sawana A., Mohamed A., Tuffner R., Mondal T. Use of Doppler velocimetry in diagnosis and prognosis of intrauterine growth restriction (IUGR): A Review. Journal of Neonatal-Perinatal Medicine. 2016;9(2):117–126. doi: 10.3233/NPM-16915132. [DOI] [PubMed] [Google Scholar]
  • 8.Fadda G. M., Cherchi P. L., D'Antona D., et al. Umbilical artery pulsatility index in pregnancies complicated by insulin-dependent diabetes mellitus without hypertension. Gynecologic and Obstetric Investigation. 2001;51(3):173–177. doi: 10.1159/000052919. [DOI] [PubMed] [Google Scholar]
  • 9.Baschat A. A. Neurodevelopment after fetal growth restriction. Fetal Diagnosis and Therapy. 2014;36:136–142. doi: 10.1159/000353631. [DOI] [PubMed] [Google Scholar]
  • 10.Sung I.-K., Vohr B., Oh W. Growth and neurodevelopmental outcome of very low birth weight infants with intrauterine growth retardation: Comparison with control subjects matched by birth weight and gestational age. The Journal of Pediatrics. 1993;123(4):618–624. doi: 10.1016/S0022-3476(05)80965-5. [DOI] [PubMed] [Google Scholar]
  • 11.Von Beckerath A.-K., Kollmann M., Rotky-Fast C., Karpf E., Lang U., Klaritsch P. Perinatal complications and long-term neurodevelopmental outcome of infants with intrauterine growth restriction. American Journal of Obstetrics and Gynecology. 2013;208(2):130–e6. doi: 10.1016/j.ajog.2012.11.014. [DOI] [PubMed] [Google Scholar]
  • 12.Hack M., Schluchter M., Cartar L., Rahman M., Cuttler L., Borawski E. Growth of very low birth weight infants to age 20 years. Pediatrics. 2003;112(1, Pt 1):e30–e38. doi: 10.1542/peds.112.1.e30. [DOI] [PubMed] [Google Scholar]
  • 13.Crume T. L., Scherzinger A., Stamm E., et al. The Long-term impact of intrauterine growth restriction in a diverse US cohort of children: The EPOCH study. Obesity. 2014;22(2):608–615. doi: 10.1002/oby.20565. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Llurba E., Baschat A. A., Turan O. M., Harding J., McCowan L. M. Childhood cognitive development after fetal growth restriction. Ultrasound Obstet Gynecol. 2014;41(4):383–389. doi: 10.1002/uog.12388. [DOI] [PubMed] [Google Scholar]
  • 15.Sovio U., White I. R., Dacey A., Pasupathy D., Smith G. C. Screening for fetal growth restriction with universal third trimesterultrasonography in nulliparous women in the Pregnancy Outcome Prediction (POP) study: a prospective cohort study. Lancet. 2015;386(10008):2089–2097. doi: 10.1016/S0140-6736(15)00131-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Als H., Duffy F. H., McAnulty G. B., et al. Is the Newborn Individualized Developmental Care and Assessment Program (NIDCAP) effective for preterm infants with intrauterine growth restriction. Journal of Perinatology. 2011;31(2):130–136. doi: 10.1038/jp.2010.81. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Als H., Duffy F. H., McAnulty G., et al. NIDCAP improves brain function and structure in preterm infants with severe intrauterine growth restriction. Journal of Perinatology. 2012;32(10):797–803. doi: 10.1038/jp.2011.201. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Toumba M., Hadjidemetriou A., Topouzi M., et al. Evaluation of the auxological and metabolic status in prepubertal children born small for gestational age. Journal of Pediatric Endocrinology and Metabolism. 2005;18(7):677–688. doi: 10.1515/jpem.2005.18.7.677. [DOI] [PubMed] [Google Scholar]
  • 19.Yamada R. T., Leone C. R. Intrauterine growth restriction and zinc concentrations in term infants during the first month of life. Journal of the American College of Nutrition. 2008;27(4):485–491. doi: 10.1080/07315724.2008.10719729. [DOI] [PubMed] [Google Scholar]

Articles from BioMed Research International are provided here courtesy of Wiley

RESOURCES